Correlation between paclitaxel Tc > 0.05 and its therapeutic efficacy and severe toxicities in ovarian cancer patients

Correlation between paclitaxel Tc > 0.05 and its therapeutic efficacy and severe toxicities in ovarian cancer patients

Aim: Although paclitaxel (PTX) is a widely used chemotherapeutic agent across many cancer types, the correlation between its concentration and treatment efficacy and toxicity is yet to be clarified. Hence, the study aims to determine the correlation between PTX Tc > 0.05 and its therapeutic effic...

Full description

Bibliographic Details
Main Authors: Shuyao Zhang, Muyin Sun, Yun Yuan, Miaojun Wang, Yuqi She, Li Zhou, Congzhu Li, Chen Chen, Shengqi Zhang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Cancer Translational Medicine
Subjects:
Blood concentration
ovarian cancer
paclitaxel
Tc > 0.05
Online Access:http://www.cancertm.com/article.asp?issn=2395-3977;year=2016;volume=2;issue=5;spage=131;epage=136;aulast=Zhang

Internet

http://www.cancertm.com/article.asp?issn=2395-3977;year=2016;volume=2;issue=5;spage=131;epage=136;aulast=Zhang

Similar Items